A Cluster-Randomized, Controlled Trial of a Simplified Multifaceted Management Program for Individuals at High Cardiovascular Risk (SimCard Trial) in Rural Tibet, China, and Haryana, India

Background— In rural areas in China and India, the cardiovascular disease burden is high but economic and healthcare resources are limited. This study (the Simplified Cardiovascular Management Study [SimCard]) aims to develop and evaluate a simplified cardiovascular management program delivered by community health workers with the aid of a smartphone-based electronic decision support system. Methods and Results— The SimCard study was a yearlong cluster-randomized, controlled trial conducted in 47 villages (27 in China and 20 in India). Recruited for the study were 2086 individuals with high cardiovascular risk (aged ≥40 years with self-reported history of coronary heart disease, stroke, diabetes mellitus, and/or measured systolic blood pressure ≥160 mm Hg). Participants in the intervention villages were managed by community health workers through an Android-powered app on a monthly basis focusing on 2 medication use and 2 lifestyle modifications. In comparison with the control group, the intervention group had a 25.5% (P<0.001) higher net increase in the primary outcome of the proportion of patient-reported antihypertensive medication use pre- and post-intervention. There were also significant differences in certain secondary outcomes: aspirin use (net difference: 17.1%; P<0.001) and systolic blood pressure (–2.7 mm Hg; P=0.04). However, no significant changes were observed in the lifestyle factors. The intervention was culturally tailored, and country-specific results revealed important differences between the regions. Conclusions— The results indicate that the simplified cardiovascular management program improved quality of primary care and clinical outcomes in resource-poor settings in China and India. Larger trials in more places are needed to ascertain the potential impacts on mortality and morbidity outcomes. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT01503814.

[1]  Joel E Williams,et al.  Improving Hypertension Self-Management With Community Health Coaches , 2015, Health promotion practice.

[2]  D. Peiris,et al.  Use of mHealth Systems and Tools for Non-Communicable Diseases in Low- and Middle-Income Countries: a Systematic Review , 2014, Journal of Cardiovascular Translational Research.

[3]  V. Ajay,et al.  A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale , 2014, BMC Public Health.

[4]  Sisira Edirippulige,et al.  Evaluating the use of mobile phone technology to enhance cardiovascular disease screening by community health workers , 2014, Int. J. Medical Informatics.

[5]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[6]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[7]  V. Patel,et al.  Effectiveness of a community-based intervention for people with schizophrenia and their caregivers in India (COPSI): a randomised controlled trial , 2014, The Lancet.

[8]  E. DeLong,et al.  Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial , 2014, BMC Public Health.

[9]  Adolfo Rubinstein,et al.  The impact of mobile health interventions on chronic disease outcomes in developing countries: a systematic review. , 2014, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

[10]  N. Wong,et al.  Cardiovascular risk factor control and adherence to recommended lifestyle and medical therapies in persons with coronary heart disease (from the National Health and Nutrition Examination Survey 2007-2010). , 2013, The American journal of cardiology.

[11]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[12]  Ralph L. Sacco,et al.  American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 Update: A Scientific Statement for Public Health Practitioners, Healthcare Providers, and Health Policy Makers , 2013, Circulation.

[13]  O. Franco,et al.  Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review , 2013, BMC Public Health.

[14]  Robert Dufour,et al.  2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. , 2013, The Canadian journal of cardiology.

[15]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[16]  Lijing L. Yan,et al.  Prevalence, awareness, treatment, and control of hypertension among herdsmen living at 4,300 m in Tibet. , 2012, American journal of hypertension.

[17]  J. Donovan,et al.  A Polypill for All? Critical Review of the Polypill Literature for Primary Prevention of Cardiovascular Disease and Stroke , 2012, The Annals of pharmacotherapy.

[18]  R. Dandona,et al.  The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. , 2012, Journal of the American College of Cardiology.

[19]  M. Hill,et al.  Community Outreach and Cardiovascular Health (COACH) Trial: A Randomized, Controlled Trial of Nurse Practitioner/Community Health Worker Cardiovascular Disease Risk Reduction in Urban Community Health Centers , 2011, Circulation. Cardiovascular quality and outcomes.

[20]  Martin McKee,et al.  Priority actions for the non-communicable disease crisis , 2011, The Lancet.

[21]  Rajeev Gupta,et al.  Interventions for cardiovascular disease prevention. , 2011, Cardiology clinics.

[22]  Vikram Patel,et al.  Chronic diseases and injuries in India , 2011, The Lancet.

[23]  A. Alwan.  Global status report on noncommunicable diseases 2010. , 2011 .

[24]  [Chinese guidelines for prevention of cardiovascular diseases]. , 2011, Zhonghua xin xue guan bing za zhi.

[25]  W. Elliott.  Community-Based Interventions to Promote Blood Pressure Control in a Developing Country: A Cluster Randomized Trial , 2010 .

[26]  S. MacMahon,et al.  Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India. , 2009, American heart journal.

[27]  B. Yawn,et al.  Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. , 2009 .

[28]  U. P. S. T. Force.  Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement , 2009, Annals of Internal Medicine.

[29]  B. Shah,et al.  Prevalence of risk factors for non-communicable disease in a rural area of Faridabad district of Haryana. , 2008, Indian journal of public health.

[30]  Zuo Chen,et al.  Estimation of 10-Year Risk of Fatal and Nonfatal Ischemic Cardiovascular Diseases in Chinese Adults , 2006, Circulation.

[31]  Milton C Weinstein,et al.  Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis , 2006, The Lancet.

[32]  Milton C. Weinstein,et al.  Cost-Effectiveness Analysis of Hypertension Guidelines in South Africa: Absolute Risk Versus Blood Pressure Level , 2005, Circulation.

[33]  Evangelos Evangelou,et al.  Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART). , 2005, Contemporary clinical trials.

[34]  George A. Mensah,et al.  The atlas of heart disease and stroke , 2005 .

[35]  N J Wald,et al.  Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials , 2003, BMJ : British Medical Journal.

[36]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[37]  Anthony Rodgers,et al.  Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk , 2003, The Lancet.

[38]  K. Reddy,et al.  Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action , 2002, Public Health Nutrition.

[39]  W. Haskell,et al.  Effect of long-term community health education on blood pressure and hypertension control. The Stanford Five-City Project. , 1990, American journal of epidemiology.

[40]  C. Dolea,et al.  World Health Organization , 1949, International Organization.